 | |
- close
- close
|
PR Newswire
Nov 24
Comment
PLEASANTON, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it will be participating
StreetInsider.com
Nov 17
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Thoratec+%28THOR%29+Releases+Data+for+HeartMate+II+Pivotal+Trial/5117185.html for the full story.
PR Newswire
Nov 10
Comment
PLEASANTON, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it will be participating in
newratings.com
Nov 6
Comment
NEW YORK, November 5 (newratings.com) - Analysts at Piper Jaffray upgrade Thoratec (ticker: THOR) from "neutral" to "overweight." The target price has been raised from $31 to $37. [more]
Market Intelligence Center
Nov 5
Comment
Thoratec (THOR) was upgraded today by analysts at Piper Jaffray and the stock is now at $29.12, up $2.13 (7.89%) on volume of 2,214,971 shares traded. The brokerage lifted the stock to Overweight from Neutral. Over the last 52 weeks the stock has...
StreetInsider.com
Nov 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Natixis+Bleichroeder+Upgrades+Thoratec+%28THOR%29+to+Buy/5078650.html for the full story.
StreetInsider.com
Nov 4
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Thoratec+%28THOR%29+Tops+Q3+EPS+by+3c%3B+Guides/5075769.html for the full story.
PR Newswire
Nov 4
Comment
PLEASANTON, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that revenues for the third
PR Newswire
Oct 27
Comment
PLEASANTON, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
THOR AT A GLANCE
References
| ||||||
|
|
